RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496

RBC Capital analyst Ben Hendrix has maintained an 'Outperform' rating on HCA Healthcare (NYSE: HCA) and increased the price target from $435 to $496. This adjustment reflects a positive outlook on the company's performance.